# Norion Bank full analys 2026-05-26

**Status:** Komplett svensk aktieanalys enligt checklistan. Detta är analys, inte investeringsråd.  
**Bolag:** Norion Bank AB (publ). **Ticker:** NORION. **ISIN:** SE0017831795. **Marknad:** Nasdaq Stockholm, Mid Cap.  
**Senaste kontrollerade kurs:** 59,1 SEK. **Aktier:** 189 782 534. **Börsvärde:** cirka 11 216 MSEK.  
**Källklassning:** Fakta, Tolkning, Antagande och Sentiment/lead skiljs åt där det spelar roll.


## Executive summary

Norion Bank is a profitable Swedish-listed specialist bank, not a clean universal-bank compounder and not a distressed basket case. At 59,1 SEK and 189 782 534 issued shares, the market cap is about 11 216 MSEK, or roughly 1,15x Q1 2026 equity and 7,8x FY 2025 net profit. That is optically cheap if Norion can sustain mid-teens ROE and keep buying back stock. It is not obviously cheap if the high Stage 3 book, Real Estate concentration and unresolved AML/FI matter consume the surplus capital. That tension is the whole case; everything else is decoration with a bank license.

The attractive part is real. FY 2025 net profit was 1 438 MSEK, ROE was 15,5%, CET1 ended at 15,6%, total capital was 18,4%, and the bank returned capital aggressively through a 1 000 MSEK 2025 buyback and cancellation of 15 598 470 shares in February 2026. Q1 2026 still showed 301 MSEK net profit, 14,0% ROE adjusted for excess capital, LCR of 490% and NSFR of 128%. A lender with that capital, liquidity and earnings base deserves analysis before dismissal.

The uncomfortable part is also real. Q1 2026 gross Stage 3 loans were 10 633 MSEK, equal to 18,8% of gross loans, with net Stage 3 still 11,4%. Real Estate was 42% of the loan book, and Norion states that net interest income is still negatively affected by high Stage 3 volumes, primarily in Real Estate. FI's AML investigation remains unresolved after a preliminary breach assessment and sanction-process handoff. If someone says this is just a low-P/E bank, check whether they also read past page one. That is where the actual work starts.

My final view is conditional rather than theatrical: Norion is a value/quality-improvement case. The equity becomes compelling if gross and net Stage 3 decline, credit losses stay around or below 1,7%, CET1 remains comfortably above target after buybacks and AT1, and the Balder distribution improves free float without endless technical selling. It becomes a value trap if Stage 3 proves structural, AML remediation bites, funding costs rise, or capital returns outpace true surplus capital. The base case is cautiously constructive but not clean enough to deserve a quality-bank multiple today.

## Company and share identity

Norion Bank AB (publ) is a Nordic financing bank operating under the Norion Bank, Walley and Collector brands. It is headquartered in Sweden and listed on Nasdaq Stockholm, segment Mid Cap. The ticker is NORION and the ISIN is SE0017831795. The current analysis date is 2026-05-26. The latest checked quote is 59,1 SEK from Inderes on 2026-05-26, cross-checked against Börsdata's 58,6 SEK previous close. The share count after the February 2026 cancellation is 189 782 534 shares and votes.

The bank's own positioning is business-oriented specialist finance rather than universal banking. Corporate lending, real estate lending, consumer finance and Walley payments make up the operating core. Recent acquisitions in Consensus Asset Management and Strand Kapitalförvaltning add a Wealth Management leg, but that is still a sidecar compared with the balance sheet. The listing is large enough for institutional investors, but the share has been heavily affected by ownership mechanics around Balder's distribution of 90 501 180 Norion shares.

The formal market cap is about 11 216 MSEK at the checked price. That puts Norion firmly in midcap territory in Sweden. The analytical routing is therefore common checklist plus Mid Cap module and a custom bank/specialty-finance module. The microcap module is not active. Pretending this is a microcap would add noise; pretending it has large-bank asset quality would be worse.

## Business model

Norion earns primarily from net interest income. In Q1 2026, net interest income was 813 MSEK out of 913 MSEK total income, roughly 89%. In FY 2025, NII was 3 460 MSEK out of 3 847 MSEK, about 90%. Payments, fees and Wealth Management matter strategically, but the current economics are still spread lending plus credit underwriting. That matters because revenue quality is not judged like SaaS revenue; it is judged after credit losses, funding cost and capital consumption.

Corporate lending serves small and mid-sized companies with secured lending and factoring-like solutions. Real Estate lending finances property borrowers across Sweden, Finland, Germany, Denmark and other markets. Consumer finance includes personal loans and credit cards, mostly in Sweden. Walley provides checkout, invoice and payment solutions to merchants and consumers. The model has attractive niches, but each one brings its own risk: real estate collateral, consumer credit conduct, merchant dependency, fraud, deposit funding and regulatory oversight.

Walley is the best growth narrative. Q1 2026 Payments transaction volume was 5 519 MSEK, up 24% YoY, with 6.8m active customers LTM, NIM of 10.1% and income margin of 17.0%. It is a real asset, not a marketing trinket. But it is still 7% of the loan book, so it cannot carry the whole valuation yet. The correct treatment is optionality with risk controls, not a fintech multiple taped to a bank balance sheet.

## Segment economics

Corporate had a Q1 loan book of 11 959 MSEK, 23% of loans, Q1 income of 190 MSEK, NIM of 5.9% and operating profit of 138 MSEK. Average loan size was SEK 52m and remaining maturity 22 months. This is classic specialist SME/entrepreneur finance: potentially attractive spreads, short maturity and collateral support, but concentrated credit work if borrowers weaken.

Real Estate is the valuation hinge. Q1 loan book was 21 604 MSEK, or 42% of loans. Income was 251 MSEK, NIM was 4.8%, operating profit was 159 MSEK, senior loans were 65%, average loan was SEK 109m and average LTV was 65% for senior and 79% for junior. Real Estate income fell sharply versus a Q1 2025 boosted by Stage 3 interest receipts. Investors should track absolute Stage 3, collateral recoveries and junior exposure before treating book value as clean.

Consumer had a Q1 loan book of 13 956 MSEK, income of 285 MSEK, NIM of 7.8% and operating profit of 114 MSEK. This was the clearest profit recovery in Q1, helped by lower credit losses from the very weak prior-year comparator. Consumer has good spread economics but also conduct, affordability, macro and regulatory sensitivity. The business is not "bad"; it is just the sort of high-yield consumer exposure that deserves a grown-up loss model.

Payments/Walley had a loan book of 3 576 MSEK, income of 153 MSEK, NIM of 10.1% and operating profit of 41 MSEK. New merchant relationships, brand awareness and transaction growth create a clear growth path. The report should watch transaction growth, take rate, merchant concentration, fraud/losses, dispute rates and consumer conduct. Walley can improve Norion's mix, but it does not repeal credit gravity.

## Income statement quality

Q1 2026 looks weak on the headline bridge: total income fell to 913 MSEK from 1 022 MSEK, operating profit fell to 389 MSEK from 525 MSEK, net profit fell to 301 MSEK from 412 MSEK, EPS fell to 1,5 from 2.01 and reported ROE fell to 12,1% from 17.8%. The trap is the comparator. Q1 2025 included about 140 MSEK of Stage 3 interest payments, mainly in Real Estate. Adjusting for that makes pre-credit earnings broadly stable rather than collapsing.

Costs still rose. Q1 expenses were 304 MSEK versus 281 MSEK and C/I increased to 33.3% from 27.5%. Some of that is denominator noise from the inflated Q1 2025 income base, but the cost trend deserves monitoring as Wealth Management and compliance expand. The bank's cost base is efficient in absolute terms, but high credit losses make operating efficiency less impressive than it first looks. A bank with good C/I and bad credit can still be a mediocre equity.

FY 2025 is the stronger baseline: total income was 3 847 MSEK, net profit 1 438 MSEK, EPS 7,1, ROE 15,5% and credit loss level 1,7%. The market question is whether FY 2025 is close to normalized earnings or flattered by recoveries, capital optimization and a credit cycle that still has heavy Stage 3 stock. The final valuation uses both FY 2025 and TTM, because neither alone is clean enough.

## Balance sheet and credit quality

The balance sheet is the core underwriting problem. Q1 gross loans were 56 884 MSEK, provisions were 5 426 MSEK, and the carrying loan book was 51 458 MSEK. Gross Stage 3 loans were 10 633 MSEK, equal to 18,8% of gross loans. Net Stage 3 was 11,4% and Stage 3 coverage was 45,2%. Those are not rounding errors. They are the reason the multiple is not cleaner.

Private-customer Stage 3 coverage was 60.3%, while corporate-customer Stage 3 coverage was 22.3%. The lower corporate coverage can be justified by collateral, but the investor must then underwrite collateral values, workout timing and borrower concentration. This is particularly important because the Real Estate segment is large and includes junior exposure. Every SEK 100m pre-tax provisioning miss is material to EPS, CET1 generation and buyback confidence.

Credit losses in Q1 were 219 MSEK, a credit loss level of 1,7%. FY 2025 credit losses were 838 MSEK, down from 1 014 MSEK in 2024. That improvement supports the bull case, but Q1 does not yet prove a decisive step down. The key proof point is not one low quarter; it is declining absolute Stage 3 without reserve releases, capital damage or a new crop of defaults. Yes, that is boring. Credit work usually is. Then it suddenly is not.

## Capital, liquidity and funding

Capital is strong today. Q1 CET1 capital was 9 006 MSEK, CET1 ratio 15,6%, total capital ratio 18,4% and reported excess capital versus the midpoint target was 1 277 MSEK. Liquidity is also strong on reported regulatory metrics: total liquidity was 15 520 MSEK, LCR 490% and NSFR 128%. That supports buybacks and mitigates any immediate funding-stress thesis.

Funding is still a risk variable. Deposits and borrowings from the public were 53 714 MSEK, or about 78% of the balance sheet. Digital/platform deposits can be rate-sensitive, and regulator treatment of deposit categories affects LCR/NSFR. Norion's rating and reputation matter because a specialist bank does not have the same deposit franchise as a universal bank. Strong liquidity ratios reduce the risk; they do not make funding cost irrelevant.

The May 2026 AT1 issue was 300 MSEK with coupon 3M STIBOR + 4.75%, perpetual and first callable after five years. It helps Tier 1 and total capital flexibility, but it does not replenish CET1 and it adds coupon cost. It is capital-stack optimization, not magic. The bank also issued Tier 2 in 2025. The final model treats AT1/T2 as supportive of regulatory capital, while common-share buyback capacity is still constrained by CET1, credit losses, RWA and regulator confidence.

## Capital returns and dilution

Norion's capital return is the cleanest per-share lever. The bank repurchased about 1 000 MSEK in 2025 and cancelled 15 598 470 shares in February 2026. In 2026, it launched a new program of up to 500 MSEK. Through 2026-05-22, it had repurchased 5 904 400 shares for about 314,6 MSEK, roughly 3.1% of issued shares.

If the full 500 MSEK is executed near 59,1 SEK, it could retire roughly 8.5m shares before price impact, about 4.5% of the starting share count. That is material for EPS and book value per external share if cancelled. The 2026 buyback was partly absorbing post-Balder distribution flow; the next question is whether the bank keeps buying once event-driven supply fades and whether shares are later cancelled.

The bank has an AGM authorization to issue up to 10% of shares. I do not model equity issuance in the base case because no such financing is signalled and Norion is buying back shares, not raising common equity. But the authorization is relevant in stress or M&A. The better base assumption is no ordinary share dilution, with AT1/T2 capital instruments treated as costed capital, not common-share dilution.

## Ownership and control

Ownership changed radically in May 2026. As of 31 March, Balder held 47.7% of Norion and Erik Selin held 21.6%. Balder then distributed 90 501 180 Norion shares, equal to 47.7% of the company, to Balder shareholders. FI flagging cited in the area reports then showed Balder near zero and Selin at 37,5%. Capital Group also appeared above 5% in flagging data. The old shareholder table is therefore stale.

This can improve the stock's investability if the distributed shares settle into a broader stable base. It can also create forced or indifferent selling from Balder holders who did not choose a specialist-bank position. The company buyback appears to have absorbed part of that flow. The final report treats the distribution as a liquidity and governance catalyst, not as a clean overhang removal until a new shareholder register and normalized trading volume prove it.

Governance is mixed. Selin's economic alignment and long operating history can be valuable. But he has historically been board chair, linked to major ownership, and central to credit/governance structures. Related-party lending was disclosed and stated to be on market terms, but it should remain visible in the risk table. Control can be a feature or a bug. Investors do not get to decide which after the fact.

## Regulatory and reputation risk

The unresolved AML/FI process is a central non-credit risk. FI initiated an AML investigation in May 2023. Norion disclosed that FI requested a statement in January 2025 after a preliminary breach assessment and that the matter moved into sanction processing. Norion answered in February 2025 and received additional questions in June 2025, October 2025 and January 2026. Q1 2026 still disclosed that timing and completion were unknown.

The equity risk is not only a fine. A sanction could add remediation cost, restrict management focus, complicate regulator dialogue, slow approvals, affect deposit confidence and make aggressive capital return harder to defend. It also matters for Walley and Consumer conduct perception. A modest fine with credible closure would remove an overhang. A severe decision or long remediation process would validate part of the valuation discount.

NCR's BB+ positive outlook helps the bear-case check: external credit observers do not appear to see immediate balance-sheet distress. But rating support is not the same as equity upside. Ratings focus on creditors and solvency; equity investors care about excess returns after losses, capital needs and dilution. The final report therefore uses rating evidence as support for funding access, not as proof that the stock is cheap.

## M&A and strategic optionality

Norion's Wealth Management push is strategically sensible but financially small today. Consensus was acquired in 2026 and Norion later controlled about 97% of shares and 96% of votes after the extended acceptance period. Strand Kapitalförvaltning was agreed on 2026-04-22, subject to FI approval and expected Q3 2026. Strand had about SEK 6bn AUM and 2025 revenue of about 29 MSEK. Together, Consensus and Strand create about SEK 15bn AUM.

This gives Norion a lower-capital-intensity fee-income angle and cross-sell access to entrepreneurs and property owners. But the scale is tiny relative to FY 2025 group income of 3 847 MSEK. The right treatment is strategic option, not immediate rerating driver. The market should look for retained AUM, fee margin, integration cost, goodwill/intangibles, client retention and evidence that Wealth Management reduces balance-sheet intensity over time.

M&A also has governance relevance. A Selin-linked bank with real estate exposure and a new Wealth Management arm may create valuable ecosystem effects, but investors must watch related-party transactions, client concentration and whether acquisitions are used to improve mix or simply add complexity. Complexity is not strategy. Sometimes it is just mess with a nicer font.

## Valuation framework

This is a bank. EV/Sales and EV/EBITDA are not meaningful primary tools because deposits, debt and interest expense are operating inputs rather than ordinary corporate financing. The correct tools are P/B, P/E, ROE, CET1, credit loss sensitivity, funding cost, capital return and book-value trust. At 59,1 SEK, Norion trades around 1,15x Q1 book, 7,8x FY 2025 earnings and 8,5x TTM earnings.

A bank earning sustainably above 15% ROE with strong capital and declining credit risk can deserve 1.25-1.50x book or more. A bank earning 12-14% ROE with high Stage 3 and regulatory uncertainty may be roughly fair around 1.0-1.2x book. A bank facing book-value impairment deserves less. Norion's current valuation sits exactly in that argument. The multiple is not dumb; it is conditional.

The scenario range used in the final table is deliberately wide. Bear value sits around SEK 42-47 if profit falls toward SEK 1.0bn, Stage 3 eats capital and buybacks slow. Base-low sits around SEK 56 if TTM-like profit and 13-14% ROE persist. Base-high sits around SEK 64-69 if profit returns toward SEK 1.45bn, Stage 3 improves slowly and buybacks continue. Bull sits around SEK 70-81 if profit reaches SEK 1.55-1.70bn, Stage 3 declines clearly and capital return stays disciplined.

The final stance is not a target price but a decision frame. At the checked price, upside exists if credit normalization becomes visible. Downside remains if asset quality disappoints. The stock is investable because capital, earnings and buybacks are real. It is not clean enough to underwrite lazily because Stage 3, AML and Real Estate are also real. Annoyingly, reality refused to be a one-line tweet.

## Catalysts

The first hard catalyst is Q2 2026, expected 14 July 2026. The report needs to show gross and net Stage 3 movement, credit loss level versus 1,7%, Real Estate NIM, Consumer loss trend, Walley volume and loss quality, CET1 after buybacks, and any early effect from Consensus. If Stage 3 declines and credit losses stay controlled, the market can start trusting book value more. If Stage 3 stays sticky or rises, the cheap-P/E case weakens.

Q3 2026, expected 22 October 2026, should show more post-Balder ownership digestion, further buyback execution, possible Strand closing and clearer Wealth Management data. The Strand approval and integration path matter because FI approval itself is a regulator-confidence signal after an open AML matter. Wealth Management revenue will not transform 2026, but credible AUM retention can support a better mix narrative.

Other catalysts include completion and cancellation of 2026 buybacks, a new shareholder register after Balder's distribution, FI AML resolution, Walley sustaining 20%+ transaction-volume growth with controlled losses, NCR/rating developments, and deposit/funding-cost stability. Negative catalysts are the inverse: a material AML sanction, Stage 3 growth, new Real Estate losses, buyback pause, deposit cost pressure, or evidence that Balder-recipient selling persists after the corporate-action dust settles.

## Risk matrix discussion

Credit is the highest-severity risk. It is not hypothetical: Stage 3 is already large. The market will need proof that recoveries are real, collateral values hold and credit losses do not exceed the current provisioning base. The most important leading indicators are absolute Stage 3, net Stage 3, provision coverage by customer type, write-offs, credit loss level, Real Estate workouts and NIM drag from non-performing exposures.

AML/FI is the highest non-credit overhang. A benign closure would remove a major discount. A harsh decision would hit reputation, costs and capital-return confidence. Funding is lower-probability but high-impact: deposits are the main funding source, and a niche bank with reputation stress can see deposit cost move faster than a universal bank. Liquidity ratios are excellent, but equity value is about margin and confidence, not just survival.

Governance and control are two-sided. Selin alignment can improve discipline and strategic patience. It can also cap the minority multiple if investors worry about related-party lending, credit decisions, take-private optionality or transaction opacity. Walley conduct and consumer lending regulation are medium-severity risks that can grow if volumes expand faster than control systems. M&A integration is lower severity today because the acquisitions are small, but it becomes more important if goodwill and fee-income promises grow.

## Council judgement

The three synthesis agents converged on the same core conclusion: Norion is a value/quality-improvement case whose valuation depends on credit normalization, not a simple cheap-bank screen. Agent 1 emphasized capital return, Stage 3 and the need for visible cleanup. Agent 2 put the sharpest weight on credit quality and warned that Wealth Management should not be overcapitalized. Agent 3 framed the case around book-value trust, Real Estate and the danger of mistaking arithmetic for underwriting. None of the agents argued for a clean distress case or a clean quality-compounder case.

I give greatest weight to the shared evidence around Stage 3, Real Estate, adjusted Q1 comparability, capital strength and buybacks. The most persuasive bullish evidence is strong capital/liquidity, FY 2025 ROE, stable adjusted pre-credit profit, Consumer/Payments momentum and actual buyback execution. The most persuasive bearish evidence is 18,8% gross Stage 3, 42% Real Estate exposure, unresolved AML/FI, deposit-platform sensitivity and control/related-party optics. The final report therefore uses a conditional, evidence-gated valuation stance.

The key disagreement is not whether Norion is profitable. It is whether those profits deserve a higher multiple before the Stage 3 stock visibly improves. I side with the cautious view: the stock can rerate, but the proof burden sits on Q2/Q3 data. Buybacks help the per-share math, but buybacks are not a substitute for credit cleanup. Calling it cheap without that condition would be analysis cosplay.

## Diligence area evidence appendix

Norion Bank - area 02: company_stock_identity. Key findings: **Hard facts.** Norion Bank AB (publ) is the listed parent company of the Norion Bank Group. The company has corporate identity number 556597-0513 and LEI 529900AGWAKUTYNETM62. It is a Swedish public limited company with domicile in Goteborg and head office at Lilla Bommens Torg 11. The business is a regulated bank under the Swedish Financial Supervisory Authority, with operations in Sweden and branches in Norway and Finland. The share trades on Nasdaq Stockholm under ticker `NORION`, in SEK, with ISIN SE0017831795. The annual report/source pack route it as Nasdaq Stockholm Mid Cap. The share was originally listed in June 2015 under Collector AB; the operating bank and listed structure later became Norion Bank after the Collector Bank AB/Collector AB merger and 2023 name change. Some older market pages and source URLs still carry Collector labels. As of 31 March 2026, Norion had 189,782,534 issued ordinary shares and votes, no treasury shares, a single share class, and one vote per share. The February 2026 cancellation removed 15,598,470 treasury shares repurchased in 2025. However, by 2026-05-22, the 2026 buyback program had rebuilt treasury holdings to 5,904,400 shares. The clean identity number is therefore 189,782,534 issued shares, while the better per-share/economic denominator after published buybacks is 183,878,134 shares outside treasury, unless later unpublished buybacks changed it. Using the 59.10 SEK quote in the source pack/Inderes, issued-share market cap is about 11.22bn SEK. Adjusted for treasury shares held through 2026-05-22, the external-share value is about 10.87bn SEK. Both numbers can be defensible, but they answer different questions. Use issued market cap for market-data reconciliation; use treasury-adjusted shares when analyzing EPS accretion an

Norion Bank - area 02: company_stock_identity. Valuation/per-share implications: For the valuation agents, the clean bridge is: - Issued shares/votes: 189,782,534. - Published treasury shares as of 2026-05-22: 5,904,400. - Shares outside treasury: 183,878,134. - Price used in source pack: 59.10 SEK. - Market cap on issued shares: about 11.22bn SEK. - Equity value on shares outside treasury: about 10.87bn SEK. The distinction affects P/E, P/B, ROE per-share framing, and buyback accretion. Q1 2026 EPS used 189,782,534 average shares because there were no treasury shares at 31 March after cancellation. That denominator is already stale for a May 2026 valuation if buybacks continue. Use the issued-share market cap when matching third-party data; use treasury-adjusted shares when modeling economic ownership and per-share effects. The no-dividend AGM decision also matters. Capital return is a buyback/capital-structure story, not a cash-yield story. That puts more weight on price paid, capital constraints, and whether repurchases are made below or above intrinsic value/book-value logic.

Norion Bank - area 03: source_collection. Key findings: Fakta: The shared source pack is usable as the parent source map. It includes the three highest-value primary files: Q1 2026 interim report, 2025 annual report and FI-approved 2026 base prospectus. Those cover core financials, capital, Stage 3, ownership, funding, audit, risk disclosures and post-period events. The latest hard financial source is Q1 2026, not FY 2025. Q1 confirms a 51,458m loan portfolio, 913m total income, 301m net profit, EPS 1.54, ROE 12.1%, CET1 15.6%, total capital 18.4%, and buybacks up to about 500m. Q1 2025 comparability is messy because Norion says it benefited by about 140m from Stage 3 interest payments. The most important post-period ownership source is not Norion's 31 March shareholder page but Balder's 11 May 2026 distribution release. The Norion holder table is still useful as a pre-distribution snapshot, but any final ownership analysis must adjust for Balder distributing 90,501,180 shares, corresponding to 47.7% of Norion. The regulatory risk source base is unusually important. The FI-approved prospectus and Q1 report both keep the AML investigation alive as unresolved. Q1 says Norion responded to additional FI questions on 12 June 2025, 27 October 2025 and 22 January 2026, and that timing was still unknown when Q1 was finalized. Tolkning: Source quality is good for accounting and capital, acceptable for market data, and weak for post-distribution ownership flows and retail/customer sentiment. The main trap is treating clean headline metrics as self-explanatory while ignoring that Stage 3 remains high, Q1 2025 had a Stage 3 interest effect, and the AML process is not closed. The source pack mostly avoids junk. Forum snippets and customer-review pages add little unless a downstream agent finds a recurring, verifiable complaint pattern ti

Norion Bank - area 03: source_collection. Valuation/per-share implications: The source base supports P/E, P/B, ROE, CET1 and buyback-capacity work, but only with caveats attached. At 59.10 SEK and 189.782534m shares, market cap is about 11.2bn SEK, supported by Inderes. Q1 equity of 9,769m implies P/B around 1.15x, and FY 2025 net profit of 1,438m implies simple trailing P/E around 7.8x. Those multiples should not be used naked. The earnings base is affected by Stage 3 interest/payment dynamics, credit-loss assumptions, real-estate exposure and regulatory cost/sanction risk. This supports valuation scenarios, not a single clean multiple. Capital-return analysis has usable inputs: CET1 15.6%, total capital 18.4%, Q1 buyback approval up to about 500m, no treasury shares after cancellation, and the 300m AT1 settling 2026-05-26. Valuation agents should test buyback sustainability under credit deterioration or an FI sanction.

Norion Bank - area 04: business description. Key findings: **Hard facts** - Fakta: Norion is not a universal bank. It is a specialist financing bank positioned as a complement to traditional large banks, with a product set centered on lending, factoring, payments and consumer finance. - Fakta: The Q1 2026 loan book is dominated by Real Estate and Consumer: 42% and 27% respectively. Corporate is 23% and Payments is 7%. - Fakta: Corporate targets medium-sized companies with collateralized lending and factoring. Q1 commentary states a SEK 30-300m lending range. - Fakta: Real Estate provides both senior and junior secured lending. It is the largest business by loan book and a strategic focus area, with exposure across the Nordics and Germany. - Fakta: Consumer operates under Collector, offering unsecured personal loans, credit cards and savings. DNB Sweden's credit-card portfolio materially broadened the card book in 2025. - Fakta: Payments operates under Walley and serves merchants with checkout/payment solutions plus end-customer invoice and instalment products. In Q1 2026 Walley had SEK 5,519m transaction volume, +24% YoY, and 6.8m active customers. - Fakta: Wealth Management is being built through M&A. Consensus is completed; Strand is agreed but still subject to FI approval, expected in Q3 2026 according to Q1/MFN disclosure. **Interpretation** - Tolkning: The business is a regulated balance-sheet lender with a faster-growing payments layer and a nascent capital-light wealth-management adjacency. "Niche bank" is accurate but too vague to be useful. - Tolkning: Real Estate is the economic center of gravity because it is 42% of Q1 loan book and contains both senior and junior lending. That creates higher spread opportunity, but also makes the business description inseparable from collateral quality and borrower concentration. -

Norion Bank - area 04: business description. Valuation/per-share implications: Norion should not be valued like a simple consumer lender or a clean payments company. Most book value and risk-weighted exposure sits in lending, especially Real Estate, Corporate and Consumer. P/B and ROE durability therefore depend on credit quality, provision adequacy, CET1 needs and sustainable net interest margins. Payments and Wealth Management can support a higher multiple only if they become large enough and demonstrably less capital-intensive. Payments has growth and merchant relevance, but remains 7% of Q1 loan book. Wealth Management has about SEK 15bn combined AUM, but the immediate revenue scale is small relative to bank income. Per-share upside needs mix shift plus stable credit losses; downside is lending losses consuming capital that could otherwise support buybacks and multiple expansion.

Norion Bank - area 05: business model & revenue quality. Key findings: **Hard facts.** Norion is still overwhelmingly a spread lender. In Q1 2026, net interest income was SEK 813m, or about 89% of total income. Net commission income was SEK 76m, about 8% of total income. FY 2025 shows almost the same structure: SEK 3,460m of net interest income and SEK 303m of net commission income. The business model is not yet fee-led; the fancy bits are garnish, not the meal. The segment mix is more nuanced. In Q1 2026, Corporate produced SEK 190m income from 23% of the loan book, Real Estate SEK 251m from 42%, Consumer SEK 285m from 27%, and Payments SEK 153m from 7%. Payments is the revenue-density standout: Q1 total income margin was 17.0%, NIM was 10.1%, transaction volume grew 24% to SEK 5,519m, and active customers rose to 6.8m from 5.7m. Consumer also carries attractive headline yield: Q1 NIM was 7.8% and total income margin was 8.3%, with the loan book up 16% year over year. Corporate and Real Estate are lower-yielding, more relationship/collateral-driven businesses, with Q1 NIM of 5.9% and 4.8%, respectively. Real Estate is the largest loan segment and the weakest quality signal: high Stage 3 volumes still hurt net interest income, and Q1 2025 benefited from about SEK 140m of Stage 3 interest receipts, making year-over-year comparisons dirty. **Interpretation.** The strongest business-model quality is not pure growth, but a mix where higher-yield Consumer/Payments can gradually dilute Real Estate concentration while Wealth Management may add capital-light fees. The issue is timing and scale. Payments is attractive but still only 7% of loans. Wealth Management is sensible, but Strand's 2025 revenue of about SEK 29m is less than 1% of Norion's FY 2025 total income. Even with Consensus, this is not a near-term transformation unless cross-selling a

Norion Bank - area 05: business model & revenue quality. Valuation/per-share implications: For valuation, this area argues for separating headline earnings power into three buckets. First, mature spread lending in Corporate/Real Estate deserves a bank-like P/E or P/B frame tied to normalized credit losses and CET1. Second, Consumer/Payments deserve a higher revenue-quality score only if credit losses and customer acquisition costs prove controlled through the cycle. Third, Wealth Management optionality should be valued cautiously until fee income is visible in group numbers. The share price can rerate if the market believes Norion can sustain mid-teens ROE with lower Stage 3 drag. Q1 reported ROE was 12.1%, or 14.0% adjusted for excess capital, below the above-15% target but not broken. The bear case is simple: if 6-10% NIM segments need persistent 1.7% group credit losses plus elevated Stage 3, the apparent cheap P/E is partly payment for asset-quality risk. The bull case is also simple: if credit quality normalizes while Payments and Wealth Management grow, the same balance sheet can produce cleaner recurring income, more excess capital and higher buyback capacity.

Norion Bank - area 06: product_technology_ip_regulation. Key findings: **Hard facts.** Norion is not a pure software company; it is a regulated specialist bank whose product stack mixes lending, cards, deposits, factoring, payment checkout, invoice/instalment credit and wealth-management acquisitions. The product/technology area that matters most for differentiation is Walley. In Q1 2026, Payments was only 7% of the loan book, but generated SEK 153m of quarterly income and had a 10.1% NIM, so even a small balance-sheet share can matter for mix. Walley's reported traction is real enough to take seriously: SEK 5,519m transaction volume in Q1 2026, up 24% YoY, 6.8m active customers, and merchant relationships including Parfym.se and Nordic Feel. The annual report also names Babyshop Group, Lager 157, Nordiska Galleriet, Lanna Mobler, Bokus and Akademibokhandeln. The Lager 157 case study frames Walley as omnichannel infrastructure linking stores, e-commerce, loyalty and customer data, which is more useful evidence than a generic "fintech platform" label. **Interpretation.** Walley's moat is probably not technical IP in the patent sense. The more defensible parts are merchant integration work, checkout conversion know-how, local Nordic payment methods, loyalty functionality, data/credit scoring, and Norion's regulated-bank balance sheet. That can still be valuable, but it is operational defensibility, not a winner-takes-all software asset. Norion's regulatory position is a double-edged asset. The banking license enables lending, deposits, payments-adjacent credit and passported activity. It also subjects the group to FI supervision, capital/liquidity rules, AML, GDPR, DORA, consumer-credit law, marketing rules and operational-resilience obligations. This is a barrier to entry, but also creates fixed compliance cost and enforcement tail-risk. Th

Norion Bank - area 06: product_technology_ip_regulation. Valuation/per-share implications: Product/technology/regulation mainly affects Norion's valuation through the acceptable P/B and P/E multiple, not through standalone IP value. A clean Walley growth story can support a higher multiple if investors believe Payments income is scalable and defensible through integrations and customer data. The Q1 2026 Payments NIM of 10.1% and transaction-volume growth make this a positive mix argument. The offset is that Payments still uses credit exposure and regulated customer data. If credit losses, AML findings, consumer-credit rules, GDPR/DORA costs or IT incidents rise with scale, the market should not capitalize Walley like clean SaaS. It is better viewed as a high-yielding regulated payments-credit business. Regulatory outcomes can also affect CET1/buyback capacity indirectly through compliance spend, capital-return confidence, or perceived Pillar 2/control risk.

Norion Bank - area 07: market_competition. Key findings: **Fakta:** Norion's market is a portfolio of niches, not one banking market. Q1 2026 loan portfolio was SEK 51.5bn: Corporate SEK 12.0bn, Real Estate SEK 21.6bn, Consumer SEK 14.0bn and Payments/Walley SEK 3.6bn. Payments is only 7% of loan book but strategically visible because Q1 transaction volume was SEK 5.5bn, up 24% YoY, with 6.8m active customers LTM. Corporate and Real Estate are 65% of the loan book combined, so the "market position" that matters most for book value is still specialist credit, not the prettier fintech story. **Fakta:** The 2026 prospectus says competition for private financial services is intense and fragmented, naming Nordic universal banks, Ikano Bank, Santander Consumer Bank, NOBA, Resurs Bank and checkout/payment providers such as Qliro. Norion's own positioning is to complement large banks with tailored financing for medium-sized companies and real estate clients that fall outside standardized bank offerings. **Fakta:** Walley is growing faster than a weak Nordic ecommerce backdrop, based on Norion's Q1 and 2025 reporting, and has added named merchants such as Parfym.se, Nordic Feel, Babyshop Group, Lager 157, Nordiska Galleriet, Länna Möbler, Bokus/Akademibokhandeln and Rema 1000. However, Klarna, Qliro, Avarda/TF Bank, Resurs and bank/card alternatives mean this is not an uncontested lane. **Tolkning:** Norion's strongest competitive position appears to be "too specialized or fast for universal banks, too large/capital-heavy for smaller niche players" in Corporate and Real Estate. That can earn attractive spreads, but it is also exactly where adverse selection lives if large banks pass on risk for good reasons. The valuation premium or discount should therefore depend less on growth slogans and more on whether realized losses prove the u

Norion Bank - area 07: market_competition. Valuation/per-share implications: Market competition mainly affects Norion through sustainable ROE and the multiple investors assign to book value. If Corporate/Real Estate margins hold while Stage 3 normalizes, the market can justify valuing Norion closer to a quality specialist finance bank: higher P/B, lower perceived credit discount, and more confidence in buybacks from excess capital. If competition forces lower lending rates or if credit losses show the bank is simply taking risk rejected by universal banks, P/B should stay capped despite headline growth. Walley's competitive outcome affects optionality more than current book value. Continued 20%+ transaction-volume growth with stable margins would deserve a fintech/payments narrative inside the bank multiple; loss of merchant momentum or price pressure would reduce that option value. Wealth Management is positive for mix and capital intensity, but near-term per-share impact should be modest unless AUM scales materially beyond the announced SEK 15bn platform.

Norion Bank - area 08: customers_sales_orders. Key findings: **Hard facts.** Norion is a multi-customer-segment specialist bank, not a single-product lender. Corporate serves medium-sized companies in Sweden, Norway and Finland with secured loans and factoring, including corporate lending in the SEK 30-300m range. Real Estate serves professional property counterparties in the Nordic region and Germany, with both senior and junior loans. Consumer serves private individuals with personal loans, credit cards and savings accounts. Payments/Walley serves merchants and end customers through checkout, invoice and instalment payment solutions. Q1 2026 customer exposure was still dominated by larger-ticket corporate credit. Corporate and Real Estate were 65% of the loan portfolio combined. Corporate average loan size was SEK 52m with 22 months remaining maturity; Real Estate average loan size was SEK 109m with 16 months remaining maturity. Relationship lending and credit selection therefore matter more than mass customer count. Consumer and Payments provide broader reach, but less of the loan book: Consumer was 27% and Payments 7%. Consumer has a clearer volume funnel. Q1 2026 disclosed 58,000 customers, 105,000 cards outstanding, 45% of personal-loan sales through own channels, average personal-loan new sales of SEK 200,000 and average loan in portfolio of SEK 165,000. The 2025 annual report says the DNB Sweden credit-card portfolio acquisition increased card count from about 24,000 to about 105,000, so part of the apparent customer expansion was acquired rather than purely organic. Management argues own-channel sales improve information quality, customer relationships and eventually credit losses. That is plausible, but not proven without vintage loss data. Walley is the standout customer reach engine. Q1 2026 active customers reached 6

Norion Bank - area 08: customers_sales_orders. Valuation/per-share implications: Customers and sales affect valuation through sustainable loan growth, credit losses and confidence in ROE. If Corporate/Real Estate growth remains selective while Stage 3 exposure normalizes, the market can underwrite higher sustainable ROE and a better P/B multiple. If concentration produces fresh losses, the cheap P/E case will keep being discounted because earnings quality will look borrower-event dependent. Walley adds optionality because it brings millions of active customers, named merchant wins and high transaction growth from a small balance-sheet base. Sustained 20%+ transaction growth with controlled losses could lift the perceived quality of the group mix. Consumer own-channel progress matters similarly: better proprietary origination should, in theory, improve loss outcomes and customer lifetime value. The valuation penalty is that none of the most useful customer-quality metrics - merchant retention, channel-level loss rates, CAC or cohort profitability - are disclosed.

Norion Bank - area 09: operations. Key findings: **Hard facts.** Norion's operating model is branch-light and systems-heavy. The bank is headquartered in Gothenburg, has offices in Gothenburg, Stockholm, Helsingborg, Oslo and Helsinki, and conducts banking operations in Sweden with branches in Norway and Finland. The group has four primary operating segments: Corporate, Real Estate, Consumer and Payments, combining collateralized corporate/real estate underwriting, unsecured consumer credit, cards, deposits, factoring and Walley merchant checkout/payment flows. The staff base is growing. Average FTE increased from 382 in 2024 to 416 in 2025, and then to 452 in Q1 2026. That is a 13% YoY increase in Q1, faster than the 8% YoY loan portfolio growth. Headcount during 2025 was 519, including 479 permanent employees and 468 full-time employees. Workforce stability improved: staff turnover fell to 7% from 11%, and total sickness absence fell to 3.0% from 3.4%. The cost base is material but relatively efficient. FY 2025 operating expenses were SEK 1,171m versus SEK 1,074m in 2024. C/I moved to 30.4% from 29.1%, so 2025 was not a clean operating-leverage year. Q1 2026 expenses were SEK 304m, up from SEK 281m, while C/I worsened to 33.3% because Q1 2025 included about SEK 140m of Stage 3 interest receipts. LTM C/I was 31.9%, still low, but worse than the 25-29% levels seen in 2022-2024. The largest cost buckets are people, consultants, IT and purchased services. FY 2025 personnel expenses were SEK 476m; other operating expenses were SEK 613m; depreciation/amortization was SEK 81m. Within other expenses, consultancy was SEK 167m, IT SEK 142m, and purchased services SEK 159m. In Q1 2026, personnel expenses were SEK 132m, other expenses SEK 151m and depreciation/amortization SEK 22m. **Interpretation.** The operational upside is

Norion Bank - area 09: operations. Valuation/per-share implications: Operations affect valuation mainly through sustainable ROE, C/I, operational-risk capital, and confidence in buyback capacity. At a Q1 2026 market cap of roughly SEK 11.2bn and book equity of SEK 9.8bn, Norion needs credible mid-teens ROE with controlled risk. A low-30s C/I ratio helps, especially if Walley and Wealth Management scale. The positive per-share path: C/I stays near 30-32%, Stage 3 drag normalizes, Walley grows through existing systems, and Consensus/Strand add fee income without much balance-sheet load. That would support higher normalized earnings, capital generation and buybacks. The negative path: FTE, IT, consultancy and compliance costs keep rising faster than income, while operational-risk capital and regulatory scrutiny increase. Then P/E can look cheap while ROE and buyback capacity leak away. Do not capitalize Walley or Wealth Management optionality at a premium until the cost line proves it can scale.

Norion Bank - area 10: management_board_incentives. Key findings: **Fakta:** Norion has continuity at the top and refresh below it. Martin Nossman has been CEO since 2018 and Peter Olsson CFO since 2019. Several operating roles are newer: Alexandra Kaber, Erik Rombin and David Lundqvist entered current roles in 2024, and Real Estate head Ken Wendelin joined in 2025. This matters because 2026 execution depends on underwriting, payments growth, consumer credit discipline and Wealth Management integration. **Fakta:** The 2026 AGM expanded the Board to six elected members by adding Frida Treschow, an attorney with corporate governance, regulatory and AML/CTF training/experience per the AGM notice. The Board skill mix maps well to Norion's risk profile: Selin brings owner/operator and real estate exposure; Lindblad, Edholm and Osberg bring banking, treasury and financial-sector experience; Raoof brings credit management/NPL experience; Treschow adds legal/regulatory depth. **Fakta:** Norion says it complied with the Swedish Corporate Governance Code in 2025 without deviations and without Nasdaq-rule or stock-market-practice breaches. The Board held 26 meetings in 2025, but 19 were per capsulam, so the headline meeting count should not be over-read as 26 full deliberative sessions. **Fakta:** Governance is committee-heavy and appropriate for a bank. Current committees are Audit, Risk and Compliance, Remuneration, and Credit. Risk and Compliance now includes Frida Treschow, useful given the unresolved FI AML matter. Annual report controls include three lines of defence, risk/compliance reporting to CEO and Board, Deloitte internal audit and EY external audit. **Fakta:** Incentives are conservative. The 2026 guidelines make fixed salary, pension and benefits the default package. Ordinary variable management pay is avoided to reduce excessive

Norion Bank - area 10: management_board_incentives. Valuation/per-share implications: Good governance at Norion should mainly affect P/B, sustainable ROE confidence and the cost of equity. A specialist bank with elevated Stage 3 loans and real estate exposure needs investors to believe the Board and credit/risk functions will prevent growth from outrunning underwriting. If the current Board mix and conservative remuneration structure are trusted, Norion can justify a higher P/B for the same reported ROE. The upside case: large owner-chair alignment, meaningful CEO shareholding, fixed-heavy executive pay, active credit/risk committees and stronger legal/regulatory Board skill support confidence in buybacks and capital allocation. If the FI AML process ends poorly, if related-party optics worsen, or if buybacks look aggressive relative to asset quality, the governance premium disappears. Then the valuation conversation shifts from "cheap P/E and capital return" to "why should a controlled niche bank with regulatory overhang trade above book?" For per-share value, this area mostly affects the multiple and buyback credibility, not near-term EPS mechanics.

Norion Bank - area 11: ownership_control. Key findings: **Fakta:** The pre-distribution snapshot is highly concentrated. As of 2026-03-31, Balder held 47.7% and Erik Selin 21.6%; together 69.3% before other related/friendly holders. State Street at 6.9%, Provobis at 3.3% and JME at 2.2% were next. Only 13.3% sat in "other shareholders." **Fakta:** Balder then distributed its entire 90,501,180-share Norion stake to Balder shareholders, equal to 47.7% of Norion. This is the main 2026 ownership event. The official Norion shareholder table is therefore useful as a baseline, not as a current post-event register. **Fakta:** Erik Selin remains the practical control figure. Norion's live board page discloses 71,243,419 shares held privately/through wholly owned companies, and 73,343,419 including related parties. On 189,782,534 issued shares, that is about 37.5% and 38.7%. Excluding 5,904,400 treasury shares, related-party weight is about 39.9% of non-treasury shares: a serious blocking minority. **Fakta:** Governance mechanics reinforce that influence. Norion has one share class, one vote per share, and no found vote cap. The Nomination Committee is built from the three largest shareholders by voting rights plus the chair. Selin is chair and sits on Audit, Remuneration and Credit Committees. **Fakta:** Related-party exposure is material enough to monitor. Annual-report note 38 shows SEK 1,880m of related-party loans at 2025 year-end, down from SEK 2,330m, plus SEK 124m interest income and SEK 60m unutilized credit limits. Norion says transactions are on market terms. **Tolkning:** Balder's distribution both helps and complicates the case. It removes the listed-property-company block and may broaden free float, but it also hands a bank share to property investors and funds that may not want it. EFN reported high turnover and brokere

Norion Bank - area 11: ownership_control. Valuation/per-share implications: Ownership affects valuation through governance discount, liquidity/float, buyback accretion and strategic optionality. Selin's large position aligns him with per-share value creation, and buybacks can be accretive if below intrinsic value and supported by surplus capital. At 5,904,400 treasury shares through 2026-05-22, Norion had bought back about 3.1% of issued shares in the 2026 program. If cancelled, EPS and book value per external share improve mechanically. Minority investors may demand a discount for practical control, related-party credit exposure and uncertain post-Balder float. A concentrated controller can support disciplined buybacks, but also narrows confidence that minority interests drive every decision. For P/B, the same ROE can deserve different multiples depending on governance and credit-allocation trust. The Balder distribution may improve liquidity and institutional access over time, but the near-term effect is messy. If technical selling clears and bank investors enter, the transition can lift the multiple. If non-core holders keep selling or Selin becomes the only visible anchor, the stock can remain optically cheap for a reason.

Norion Bank - area 12: history_credibility. Key findings: **Hard facts.** Norion is the renamed and reorganized Collector structure, founded in 1999, with the bank now carrying the listed equity after the 15 August 2022 merger between Collector Bank AB and Collector AB. The name changed to Norion Bank AB on 5 September 2023. The rationale was to separate the business into Norion Bank for Corporate/Real Estate, Walley for Payments, and Collector for Consumer. The transformation has produced real financial progress. From 2021 to 2025, total income rose from SEK 2.6bn to SEK 3.8bn, net profit from SEK 753m to SEK 1,438m, EPS from SEK 3.47 to SEK 7.12, and equity from SEK 5.4bn to SEK 9.5bn. ROE was 15.5% in 2025 versus the above-15% target, and adjusted for excess capital the bank reports 17.0%. Credit loss ratio improved from 2.6% in 2021 and 2.1% in 2024 to 1.7% in 2025. **Interpretation.** Credibility is mixed, not binary. The bank has delivered earnings, capital build, buybacks and business mix broadening. It executed SEK 1bn of buybacks in 2025, cancelled 15.6m shares in February 2026, and launched another up-to-SEK 500m repurchase programme after Q1 2026. The capital target has also translated into T2/AT1 issuance, excess capital disclosure, and surplus capital distribution by buyback. The weak point is asset quality. Stage 3 remains too large to dismiss as historical dust. At FY 2025, gross Stage 3 loans were 18.8% of gross loans and net Stage 3 loans 11.5%; Q1 2026 was essentially the same at 18.8% gross and 11.4% net. Improving credit losses, selective underwriting, a SEK 430m NPL sale to Intrum/Cerberus, and Stage 3 interest recoveries help, but the bank is still asking investors to trust workout execution. M&A is the new credibility test. Consumer and Payments growth benefited from DNB Sweden's card portfolio and Verkk

Norion Bank - area 12: history_credibility. Valuation/per-share implications: History and credibility mainly affect the allowed P/B and sustainable ROE assumptions. The bull case gets support from EPS growth, FY 2025 ROE above target, improved credit loss ratio, strong CET1, completed buybacks and a deliberate move toward less capital-intensive fees. At the source-pack market cap of about SEK 11.2bn, investors are not paying a heroic multiple for that record. The bear adjustment is straightforward: the market should not award a full quality-bank multiple while Stage 3 loans remain around 19% gross and the AML process is unresolved. A cleaner profile would mean higher confidence in mid-teens ROE, lower cost of equity, more buyback capacity and possibly a higher P/B. A worse outcome means lower normalized ROE, higher capital conservatism, reduced buybacks and a lower multiple. Per-share value is especially sensitive to whether buybacks continue from genuine surplus capital. The 2025 cancellation reduced the share count to 189.8m by Q1 2026. If earnings normalize around the 2025 level and shares shrink further, EPS math improves quickly. If Stage 3 losses or AML costs consume capital, that spreadsheet trick stops working.

Norion Bank - area 13: income statement. Key findings: **Hard facts.** Norion's Q1 2026 income statement looks weaker on reported YoY numbers but much less dramatic after adjustment. Total income fell 11% to SEK 913m, NII fell 12% to SEK 813m, operating profit fell 26% to SEK 389m and net profit fell 27% to SEK 301m. The catch, because apparently the income statement wanted a trap door, is that Q1 2025 included about SEK 140m of interest payments from Stage 3 borrowers, mainly in Real Estate. Remove that item and Q1 2025 total income was roughly SEK 882m, making Q1 2026 income slightly higher. The profit-before-credit-loss bridge is similarly less ugly. Q1 2026 profit before credit losses was SEK 609m versus SEK 741m reported in Q1 2025. Adjusting Q1 2025 for the SEK 140m Stage 3 interest item gives about SEK 601m, so pre-credit earnings were broadly stable. Expenses were SEK 304m versus SEK 281m, up 8%. Reported C/I worsened to 33.3% from 27.5%, but a normalized Q1 2025 denominator would put C/I around 31.9%. Cost efficiency deteriorated, just not catastrophically. Credit losses are the harder issue. Q1 2026 credit losses were SEK 219m versus SEK 216m in Q1 2025 and SEK 199m in Q4 2025. The credit loss level was 1.7%, slightly better than 1.8% a year earlier, but not low. FY 2025 credit losses were SEK 838m, an improvement from SEK 1,014m in 2024, but Q1 does not yet prove a step-change downward. FY 2025 is the stronger baseline. Total income rose 4% to SEK 3,847m, NII rose 4% to SEK 3,460m, operating profit rose 14% to SEK 1,838m and net profit rose 14% to SEK 1,438m. The improvement came mainly from lower credit losses and lower interest expense, not explosive revenue growth. **Segment facts.** In Q1 2026, operating profit was Corporate SEK 138m, Real Estate SEK 159m, Consumer SEK 114m, Payments SEK 41m and Other SEK -63

Norion Bank - area 13: income statement. Valuation/per-share implications: The income statement supports a cautious normalized-earnings frame rather than a blind reported P/E. At the source-pack market cap of about SEK 11.2bn, FY 2025 net profit of SEK 1,438m implies about 7.8x P/E. TTM net profit of SEK 1,327m implies about 8.5x. Those multiples look cheap, but investors need confidence that credit losses and Stage 3 drag are normalizing. Q1 2026 EPS was SEK 1.54. Reported Q1 2025 EPS was SEK 2.01, but after tax-adjusting the SEK 140m Stage 3 interest item, the underlying comparison is close to flat in net income and up on EPS because the share count fell. If Norion can keep adjusted earnings around this level while repurchasing shares and maintaining CET1, per-share value can compound even without strong topline growth. For P/B, the hinge is sustainable ROE. Q1 ROE was 12.1%, or 14.0% adjusted for excess capital. FY 2025 ROE was 15.5%. A clean mid-teens ROE bank with low-30s C/I and improving credit losses can justify a higher P/B than a bank whose earnings are hostage to Stage 3 recoveries. Shocking, I know: lenders have to prove the loans are good.

Norion Bank - area 14: balance_sheet. Key findings: **Hard facts.** Norion's balance sheet is a loan book funded mainly by public deposits. Q1 2026 total assets were SEK 68.5bn, with loans to the public of SEK 51.5bn. Deposits and borrowings from the public were SEK 53.7bn, or about 78% of the balance sheet. Senior debt was SEK 1.7bn and subordinated liabilities SEK 1.1bn at quarter-end. The loan book grew again after a flat 2025. Q1 loans were up 8% YoY and 4% QoQ. Real Estate is still the main concentration at 42% of loans, followed by Consumer at 27%, Corporate at 23% and Payments at 7%. Mix matters more than aggregate growth because Real Estate carries collateral/refinancing risk, while Consumer and Payments carry retail credit-cycle risk. Stage 3 remains the central issue. Gross loans were SEK 56.9bn and provisions SEK 5.4bn. Stage 3 gross loans were SEK 10.6bn, or 18.8% of gross loans. The ratio improved from 20.6% a year earlier but was unchanged versus year-end 2025. In absolute terms, Stage 3 increased from SEK 10.3bn at 2025 year-end to SEK 10.6bn at Q1. So the YoY ratio is better, but calling the problem solved would be spreadsheet theatre. The provision picture is mixed. Total provision ratio was 9.6%. Stage 3 provision coverage was 45.2%, almost unchanged from 45.1% at year-end 2025 and 45.3% at Q1 2025. Private-customer Stage 3 coverage was 60.3%, while corporate-customer Stage 3 coverage was 22.3%. Collateral may explain the gap, but the report does not give enough Stage 3 collateral detail to treat it as harmless. Liquidity ratios are strong on reported metrics. Total liquidity was SEK 15.5bn, including a SEK 12.2bn liquidity portfolio and SEK 3.4bn other liquid assets. LCR was 490% and NSFR 128%. The caveat is funding composition: the 2026 base prospectus states that a significant part of deposits is sou

Norion Bank - area 14: balance_sheet. Valuation/per-share implications: For valuation, area 14 points directly to P/B, ROE durability and buyback capacity. At the source-pack market cap of about SEK 11.2bn and Q1 shareholders' equity of SEK 9.77bn, the stock trades around 1.15x common book. That multiple depends on whether investors believe the bank can earn mid-teens ROE without Stage 3 consuming capital. The bull path: stable deposits, high LCR/NSFR, CET1 surplus, controlled credit losses and declining Stage 3 support buybacks and a higher P/B multiple. The bear path: if Stage 3 requires more provisions or Real Estate collateral exits are slow, reported book value and capital surplus are less valuable than they look. The May AT1 issue is not ordinary-share dilution, but it adds cost above deposits and senior debt. It is capital-efficient funding, not free capital. The per-share test is whether capital instruments plus retained earnings let Norion buy back stock while maintaining CET1 and absorbing credit risk.

Norion Bank - area 15: cash_flow_runway. Key findings: **Hard facts.** Norion is not burning cash in an operating sense. It reported SEK 301m net profit in Q1 2026 after SEK -219m credit losses, and SEK 1,438m net profit for 2025. The negative Q1 cash flow of SEK -1,400m, including SEK -1,291m from operating activities, mostly reflects loan growth, securities, deposits and other balance-sheet movements. Treating that as "cash burn" would be spreadsheet cosplay. It is a bank; the balance sheet is the product. The liquidity position is strong on reported regulatory metrics. At 31 March 2026, total liquidity was SEK 15.5bn, roughly 29% of deposits and borrowings from the public of SEK 53.7bn. LCR was 490% and NSFR 128%. Liquidity fell from SEK 16.6bn at year-end 2025, but remained large relative to near-term needs. Funding is deposit-heavy. Deposits and borrowings from the public were SEK 53.7bn and represented 78% of the balance sheet. Public deposits were split SEK 29.5bn EUR, SEK 22.3bn SEK, and SEK 1.8bn NOK in Q1 2026. Wholesale funding was modest: senior unsecured bonds SEK 1.7bn and no commercial paper outstanding. Capital is the real runway constraint. CET1 capital was SEK 9.0bn, CET1 ratio 15.6%, total own funds SEK 10.6bn, total capital ratio 18.4%, and RWEA SEK 57.6bn. Total capital requirement was 13.2%, and Norion says excess capital versus the midpoint of its target buffer was SEK 1.277bn. That surplus supports buybacks and growth, but it is not infinite given the loan book, Stage 3 exposure, and regulatory scrutiny. **Interpretation.** The current base case does not point to near-term liquidity stress. The bank has profitable operations, high liquidity ratios, a sizeable liquidity portfolio, and demonstrated access to AT1 investors in May 2026. The better question is whether management is returning too much capi

Norion Bank - area 15: cash_flow_runway. Valuation/per-share implications: Cash-flow valuation should focus on sustainable earnings, ROE, CET1 generation, and capital return rather than free cash flow. FCF-style metrics are low quality because loan growth and funding movements dominate cash flow. At the area level, the bull valuation implication is straightforward: if Norion can sustain low-to-mid-teens ROE, keep LCR/NSFR high, fund loan growth, and retire shares without impairing CET1, then P/E and P/B can re-rate. Buybacks at around the current market cap are per-share accretive if normalized credit losses are manageable. The bear implication is also simple: the market should not capitalize buybacks as clean excess value if capital is only "excess" before a credit cycle, higher platform-deposit liquidity treatment, or a regulator shock. A 500m buyback is about 4.5% of the SEK 11.2bn market cap in the source pack, but it also removes about 0.9 percentage points of CET1 ratio on Q1 RWEA. If Stage 3 loans or real estate exposures force higher provisions, the same buyback becomes lost optionality. For per-share work, model capital return as conditional. Use accounting net profit as the starting point, deduct credit-loss stress and RWEA growth, then test res

Norion Bank - area 16: accounting_quality. Key findings: **Hard facts.** Norion's accounting framework is normal for a Swedish listed bank: IFRS as adopted by the EU, Swedish credit-institution accounting law, FI rules and IFRS 9 impairment. EY's 2025 audit opinion was clean. That is the basic floor; no point pretending otherwise. The main accounting judgement is credit provisioning. At Q1 2026, Stage 3 gross loans were SEK 10,633m, equal to 18.8% of gross loans excluding POCI; after provisions, Stage 3 was still 11.4% of net loans. Total provisions were SEK 5,426m and the Stage 3 provision ratio was 45.2%, almost unchanged from 45.1% at year-end 2025 and 45.3% at Q1 2025. Private-customer Stage 3 provision coverage was 60.3%, while corporate-customer Stage 3 coverage was 22.3%, reflecting collateral assumptions in corporate and real estate lending. The 2025 auditor's only key audit matter was provisioning for expected credit losses. EY reviewed model controls, PD/LGD/EAD assumptions, stage allocation, data inputs, individual loan provisioning, collateral, model validation and manual adjustments, using internal specialists. That is a useful assurance signal, but it also identifies the fragile estimate. Norion's Stage 3 interest disclosure is good but still creates comparability noise. Q1 2025 was flattered by about SEK 140m of received interest payments from Stage 3 borrowers, boosting total income, operating profit, EPS and ROE comparisons. Norion disclosed this, but also says there were no non-recurring items in 2025. Disclosure quality is acceptable; adjusted-performance framing is less helpful. Q1 2026 was not auditor-reviewed. The annual audit gives assurance through 2025, not through the latest quarter, the Consensus post-period acquisition accounting, or the Q1 movement in Stage 3 provisions. **Interpretation.** Accoun

Norion Bank - area 16: accounting_quality. Valuation/per-share implications: Accounting quality primarily affects Norion through P/B, ROE credibility, CET1 surplus and buyback capacity. At the source-pack share price of SEK 59.10, market cap is about SEK 11.2bn and P/B is about 1.15x against Q1 equity of SEK 9,769m. That multiple needs confidence that book value is real and ROE is not being flattered by under-provisioning or lumpy Stage 3 income. Sensitivity is not academic. With 189.8m shares, every SEK 100m pre-tax provision miss is roughly SEK 79m after Swedish tax, or SEK 0.42 per share and 0.8% of Q1 book equity. The Q1 2025 Stage 3 interest effect of SEK 140m is about SEK 111m after tax, or SEK 0.59 per share. That is material versus Q1 2026 EPS of SEK 1.54. Capital is the second channel. Incremental provisions reduce retained earnings and CET1 capital, narrowing the margin for buybacks. The stock's valuation case can tolerate some credit losses; it cannot tolerate a narrative where Stage 3 improvement requires eating the excess capital that underwrites capital returns.

Norion Bank - area 17: capital_structure_dilution. Key findings: **Fakta:** Norion's common-share structure is clean today: one ordinary share class, one vote per share, 189,782,534 shares/votes after the February 2026 cancellation, and no treasury shares at Q1 publication. Basic and diluted EPS are identical in Q1 2026 and FY 2025, so no option, warrant or convertible overhang was found. **Fakta:** The real per-share story is buybacks, not fresh equity. Norion repurchased 15,598,470 shares for SEK 1,000m during 2025 and cancelled them in February 2026. Through 2026-05-22, the restarted 2026 program had bought 5,904,400 shares for about SEK 314.6m. **Fakta:** The AGM also gave the Board a 10% share issuance authorization, with or without preferential rights. It is not an announced raise, but it belongs in the diluted frame: about 18.98m possible new shares, leaving existing holders with about 90.9% of an enlarged base if fully used. **Fakta:** The regulatory capital stack uses hybrid instruments. At Q1 2026, CET1 capital was SEK 9,006m, Tier 1 capital SEK 9,506m and total own funds SEK 10,603m. This included SEK 500m AT1 and SEK 1,096m Tier 2. The May 2026 SEK 300m AT1 would add roughly 52 bps to Tier 1/total capital ratios on Q1 risk-weighted exposure if RWA and deductions are unchanged; CET1 is unchanged, because AT1 is not common equity. **Tolkning:** Norion is swapping surplus capital for fewer shares while using AT1/Tier 2 to keep the regulatory stack efficient. That works if credit losses normalize and shares are repurchased below intrinsic value. It fails if Stage 3 loans, FI/AML outcomes or acquisitions later require common equity. **Tolkning:** AT1 is not ordinary-share dilution, but common shareholders still pay for it economically. Q1 net profit was SEK 301m: SEK 291m to common shareholders and SEK 10m to AT1 holders. More

Norion Bank - area 17: capital_structure_dilution. Valuation/per-share implications: At the source-pack share price of SEK 59.10, 189,782,534 issued shares imply about SEK 11.2bn market cap. Q1 shareholder equity of SEK 9,769m implies book value per issued share of about SEK 51.5 and P/B around 1.15x. The 2026 buyback average through 2026-05-22, SEK 53.28, is slightly above Q1 book per share but below the checked market price. BVPS accretion is not automatic; EPS accretion is more plausible if earnings and capital headroom hold. If the 5,904,400 treasury shares bought through 2026-05-22 are later cancelled, issued shares would fall to 183,878,134 before further repurchases, a 3.1% gross reduction. Completing the SEK 500m program at similar prices would approach a 5% reduction. The May SEK 300m AT1 is worth roughly 52 bps of pro forma Tier 1/total capital on Q1 RWEA before movements in RWA, deductions or earnings. It supports buyback capacity but does not change common shares or CET1. The positive read is higher confidence in ROE optimization; the negative read is more hybrid capital while asset-quality risk is still high. Fully diluted analysis should use two layers: current economic share count net of treasury for near-term metrics, and a stress/authorization case

Norion Bank - area 18: issuance_financing_pattern. Key findings: **Hard facts.** Norion's recent pattern is not equity dilution. The company has used retained earnings and surplus capital to repurchase shares, while issuing regulatory capital instruments and maintaining deposit-led funding. In 2025 it repurchased 15,598,470 shares for SEK 1.0bn across two programs. Those shares were cancelled in February 2026; the share capital was kept unchanged through a bonus issue without issuing new shares. The Q1 2026 share count was 189,782,534 and Norion held no own shares at that point. The 2026 buyback program restarted the same playbook. Norion announced an up-to-SEK 500m buyback on 23 April 2026 and continued it after AGM authorization on 5 May 2026. The official buyback table shows 5,904,400 shares repurchased for SEK 314.6m through 22 May 2026, equal to about 3.1% of the Q1 share count. If those shares are later cancelled, the mechanical EPS/book-per-share effect is meaningful, although not magic; capital leaves the bank. Funding remains deposit-heavy. Q1 2026 deposits and borrowings from the public were SEK 53.714bn, about 78% of the balance sheet. Senior unsecured bonds were only SEK 1.736bn and commercial papers were SEK 0. Liquidity metrics were strong: total liquidity SEK 15.520bn, LCR 490%, NSFR 128%. That reduces near-term funding pressure, but the prospectus is clear that deposits, especially partner-channel deposits, reputation, rating and market funding appetite are real constraints. Norion has been deliberately filling out the regulatory capital stack. T2 issuance moved from SEK 300m at STIBOR + 6.50% in May 2024, to SEK 300m at +5.95% in October 2024, to SEK 500m at +4.80% in September 2025. AT1 issuance was SEK 500m at +5.90% in October 2025 and SEK 300m at +4.75% in May 2026. The lower 2025/2026 spreads are not a perfect a

Norion Bank - area 18: issuance_financing_pattern. Valuation/per-share implications: The buyback math is the clearest per-share lever. The 2025 repurchases cut the share base by 15.6m shares, about 7.6% of the pre-cancellation share count. The 2026 program had already bought 5.9m shares through 22 May 2026, about 3.1% of Q1 shares. If cancelled, this can lift EPS and book value per remaining share, assuming the purchase price is below intrinsic value and capital remains surplus. That is why the market may value Norion more on capital return capacity than on a simple headline P/E. The capital-instrument issuance affects valuation differently. AT1/T2 help Norion hold total capital and Tier 1 buffers while returning CET1-heavy surplus through buybacks. This can improve ROE and support P/B if credit losses stay manageable. The offset is coupon cost and higher loss-absorption complexity. The May 2026 SEK 300m AT1 at 3m STIBOR + 4.75% is better than common equity dilution, but not equivalent to free capital. Higher funding spreads would pressure net interest income and justify a lower P/E/P/B multiple.

Norion Bank - area 19: valuation. Key findings: **Hard facts.** At 59.10 SEK and 189.8m issued shares, Norion's market cap is about SEK 11.2bn. Against FY 2025 net profit of SEK 1.438bn, that is 7.8x earnings. Against TTM net profit of SEK 1.327bn, it is 8.5x. Q1 2026 shareholders' equity was SEK 9.769bn, so the stock trades at 1.15x book. Book value per issued share was about 51.47 SEK. The share count is moving. Q1 2026 had 189,782,534 issued shares and no treasury shares after cancellation of the 2025 repurchases. By 2026-05-22, Norion had repurchased 5,904,400 shares, spending about SEK 314.6m at an average price near 53.28 SEK. That reduces the economic external share count to 183,878,134 before later unpublished buybacks. Valuation work using only the Q1 share count is already stale. **Interpretation.** The headline valuation is not demanding for a bank that can really earn mid-teens ROE. A 1.15x P/B multiple with FY 2025 ROE of 15.5% and adjusted Q1 ROE of 14.0% is defensible if credit losses normalize and excess capital remains distributable. The problem is that the book is not a boring prime-mortgage book. Stage 3 gross loans were 18.8% of gross loans, Real Estate was 42% of the loan portfolio, and credit losses still ran at 1.7%. That is why the market is not awarding a clean quality-bank multiple. The P/E looks cheap, but the correct earnings base is debatable. Q1 2025 was inflated by about SEK 140m of pre-tax interest payments from Stage 3 Real Estate borrowers. Adjusting for that makes Q1 2026 underlying development much better than the reported YoY decline. Still, for a specialist lender, credit losses are part of the product cost. Scenario frame: | Scenario | Core assumption | Valuation frame | Implied value per share | |---|---|---:|---:| | Bear | Profit falls toward SEK 1.0bn; Stage 3 consumes earnin

Norion Bank - area 19: valuation. Valuation/per-share implications: The most useful valuation anchor is P/B cross-checked against sustainable ROE. At 1.15x book, the market is paying for some confidence that Norion can earn around its mid-teens ROE target, but not paying for a pristine balance sheet. If sustainable ROE settles around 12%, fair P/B should drift toward book or below. If ROE normalizes around 15-16% with lower Stage 3 risk, 1.25-1.50x book is plausible. P/E tells the same story. A 7.8x FY 2025 P/E and 8.5x TTM P/E look optically cheap, but those multiples are only attractive if the credit-loss line is normal rather than under-reserved. If normalized profit is closer to SEK 1.0bn, the current price is more like 11x stressed earnings. If profit returns to SEK 1.5-1.7bn and shares keep shrinking, the current price becomes 6.5-7.5x forward-like earnings. For the parent model, use three denominators: issued shares for market-data reconciliation, treasury-adjusted shares for economic per-share ownership, and fully refreshed Q2 share count when available. Mixing them makes the table lie politely.

Norion Bank - area 20: catalysts. Key findings: **Hard facts.** Norion's near-term catalyst calendar is dense. Q2 2026 reports on 14 July 2026 and Q3 2026 on 22 October 2026. Between Q1 and those prints, the company has an active buyback, Balder's 47.7% ownership distribution, a SEK 300m AT1 issue settling on 26 May 2026, and Wealth Management expansion. Norion reported 5,904,400 accumulated treasury shares by 22 May 2026. At 189,782,534 Q1 shares, that equals about 3.1% of the pre-buyback share count. The program supports EPS and ROE if credit losses and capital requirements remain stable. Credit quality is the gating catalyst. Q1 credit loss level was 1.7%, but Stage 3 gross loans remained 18.8%, with net Stage 3 at 11.4%. A clean Stage 3 decline would support lower risk premium and continued capital return. Deterioration would hit earnings, CET1 headroom, and P/B. **Interpretation.** The positive setup is excess capital plus buybacks plus lower credit risk plus added fee income. The hard part is proving credit normalization before Stage 3 consumes the capital investors assign to buybacks.

Norion Bank - area 20: catalysts. Valuation/per-share implications: At SEK 59.10, market cap was about SEK 11.2bn, with 2025 P/E about 7.8x and Q1 2026 P/B about 1.15x. The market is discounting credit, regulation, and ownership complexity. Buybacks are the most direct per-share catalyst. The 5.9m treasury shares by 22 May equal about 3.1% of the Q1 share base. If cancelled later, this improves EPS and book value per remaining share, provided the capital spent is truly surplus. Repurchases below intrinsic P/B are accretive; repurchases ahead of credit deterioration are not. Credit cleanup is the multiple catalyst. Lower Stage 3 and stable credit losses would support higher ROE confidence, lower cost of equity, and possibly higher P/B. A rise in credit losses would hit earnings, CET1 headroom, and buyback capacity. Wealth Management is more of a long-duration multiple catalyst than a 2026 EPS catalyst. Strand's SEK 29m 2025 revenue is small versus Norion's SEK 3,847m 2025 total income, but fee-income growth could reduce capital intensity over time.

Norion Bank - area 21: risk analysis. Key findings: **Fakta:** The biggest analytical risk is not that Norion lacks capital or liquidity today; it is that the bank carries a large stock of impaired loans while returning capital and leaning on confidence-sensitive funding. Q1 2026 Stage 3 gross loans were SEK 10,633m, 18.8% of gross loans, with total provisions of SEK 5,426m. The ratio has improved from Q1 2025, but a clean "normal bank multiple" still requires proof. **Fakta:** Real estate is the key concentration. It was 42% of the Q1 loan book and remains exposed to property values, refinancing markets, tenant cash flows, interest rates and cross-border execution. Average LTVs of 65% for senior and 79% for junior loans are not automatically alarming, but junior exposure has less margin for valuation error. Q1 management says senior-loan share increased to 65% from 61% last year and 56% two years ago. **Fakta:** Credit losses remain a live earnings variable. Q1 2026 net credit losses were SEK -219m against profit before credit losses of SEK 609m, so credit consumed about 36% of pre-credit operating profit in the quarter. FY 2025 credit losses were SEK -838m. The company reports a 1.7% credit loss level in both Q1 2026 and FY 2025; that is manageable if stable, but it is not low-cost-bank behavior. **Fakta:** Liquidity ratios are strong. Q1 2026 LCR was 490% and NSFR 128%, with SEK 15,520m of total liquidity. That gives room against near-term funding stress. The risk is second-order: deposit pricing, deposit-platform treatment, reputation, and refinancing terms can still move margins. **Fakta:** AML/FI risk is unresolved and serious enough to matter to equity. The base prospectus states that FI preliminarily assessed on 31 January 2025 that Norion had breached AML rules and that the case entered sanction processing. The

Norion Bank - area 21: risk analysis. Valuation/per-share implications: Risk analysis affects Norion's valuation through sustainable ROE and the acceptable P/B multiple. At the source-pack market cap of about SEK 11.2bn, Q1 book equity of SEK 9.8bn implies roughly 1.15x P/B. That can be fair if ROE moves back above 15%, credit losses normalize and AML risk clears. It can be too high if the bank is structurally a 12-14% ROE lender with elevated Stage 3 drag and a regulator overhang. Credit losses are the direct EPS lever. Annualizing Q1 net credit losses gives roughly SEK 876m, close to FY 2025's SEK 838m. A 25% adverse move in annual credit losses would be about SEK 210-220m pre-tax, material against FY 2025 net profit of SEK 1,438m. Conversely, lower Stage 3 and credit losses would support EPS, buybacks and a lower equity discount. Capital is another valuation lever. The company targets 200-400 bps buffers above regulatory requirements and distributes surplus capital when outlook and capital planning allow it. The ongoing SEK 500m buyback signals confidence, but it is conditional on the risks in this section behaving. If FI sanctions, credit losses or RWEA inflation absorb capital, the buyback story weakens.

Norion Bank - area 22: red_flags. Key findings: Hard facts: 1. The main red flag is credit quality, not some mystery scandal. Q1 2026 gross Stage 3 loans were SEK 10.6bn, equal to 18.8% of gross loans. Net Stage 3 was still 11.4%. A bank with almost one-fifth gross Stage 3 is not a "just slap a cheap P/E on it" situation unless the credit cleanup is demonstrably working. 2. Real Estate is the key problem pocket. It was 42% of Q1 loan book, and Norion states NII was still negatively affected by high Stage 3 volumes, primarily Real Estate. The prospectus says roughly 37% of real-estate credit volume was junior credit at 2025 year-end, above universal-bank financing levels. 3. FI/AML is unresolved and no longer only routine supervision. FI preliminarily assessed that Norion breached AML rules and moved the matter to sanction processing on 31 January 2025. Q1 2026 still discloses unknown completion timing. 4. Related-party lending exists at meaningful scale. The 2025 related-party balance was SEK 1.88bn in loans to related parties. The bank says these are on market terms and collateralized, which matters, but this is not a rounding error. 5. Governance is founder/owner-heavy. Selin's overlap across ownership, board chairmanship and key committees creates a control red flag, especially because the credit committee can make credit decisions under delegated authority. 6. Buybacks are a double-edged signal. SEK 1.0bn bought back in 2025 plus a new SEK 500m program in 2026 supports EPS and confidence, but the timing deserves scrutiny while AML sanction risk and high Stage 3 remain unresolved. Interpretation: The evidence does not support a fraud/aggressive-promotion thesis. The evidence does support a "cheap bank because credit/regulatory quality is messy" thesis. The cleanest bear case is that the market is correctly haircut

Norion Bank - area 22: red_flags. Valuation/per-share implications: At the source-pack share price of SEK 59.10, market cap is about SEK 11.2bn and Q1 2026 P/B is about 1.15x. The red-flag implication is simple: Norion can deserve a decent multiple only if investors believe the SEK 9.8bn equity base is clean and the SEK 10.6bn Stage 3 book is provisioned properly. The key valuation levers are: - P/B haircut: unresolved AML plus high Stage 3 can cap the multiple even if reported ROE screens fine. - ROE normalization: Q1 ROE was 12.1%, or 14.0% adjusted for excess capital. A lower credit-loss run-rate and buybacks can lift ROE; extra write-offs or sanctions can erase that. - CET1 and buyback capacity: CET1 was 15.6% against a 9.2% CET1 requirement in Q1, but distributions depend on regulator comfort and credit outcomes. A sanction or worse credit migration would compete directly with buybacks. - EPS quality: the Q1 2025 comparison included about SEK 140m Stage 3 interest receipts. Treat raw growth and TTM earnings with caution unless those items are normalized.

Norion Bank - area 24: liquidity_trading_risk. Key findings: **Fakta.** Norion is no longer trading like the sleepy small-mid financial it was in 2024. Nasdaq's 2024 annual statistics show average daily turnover of SEK 5.0m and average daily volume of 121,371 shares. In 2025 that rose to SEK 12.5m and 224,492 shares, with turnover velocity increasing from 16.90% to 21.55%. That was a real improvement before the Balder event, not just one weird week. **Fakta.** May 2026 liquidity is far above that historical baseline, but it is contaminated by corporate action flows. MarketScreener showed 20-session average volume of about 1.98m shares and average 20-session turnover of about SEK 117.6m on 2026-05-26. The same page showed 2026-05-26 daily volume of about 595k shares, while StockAnalysis showed 587k shares at 16:56 CET. Inderes showed SEK 34.24m turnover at a SEK 59.10 price. **Fakta.** Balder distributed 90,501,180 Norion shares, equal to 47.7% of Norion, to Balder shareholders. Balder shares traded ex-distribution from 2026-05-11 and record date was 2026-05-12. Only whole Norion shares were distributed; fractions were aggregated and sold through Nasdaq Stockholm. That creates a forced/administrative flow independent of Norion fundamentals. **Fakta.** The company is itself a major buyer. The 2026 buyback page shows repurchases of 159,400 shares during 2026-04-23 to 2026-04-30, 1,267,000 during 2026-05-04 to 2026-05-08, 2,151,000 during 2026-05-11 to 2026-05-15 and 2,327,000 during 2026-05-18 to 2026-05-22. That totals 5,904,400 shares and approximately SEK 314.6m through 2026-05-22, or about 3.1% of the 189.8m shares. **Tolkning.** The share has a short-term liquidity sweet spot: a large holder distribution pushed shares into new accounts just as the company is buying aggressively. This improves tradability and may reduce the hist

Norion Bank - area 24: liquidity_trading_risk. Valuation/per-share implications: Liquidity does not directly change credit losses, ROE or CET1, but it can change the multiple investors are willing to pay for the same fundamentals. If the Balder distribution produces a genuinely broader float and daily turnover stays higher, Norion's P/E and P/B could carry a smaller control/liquidity discount. That is especially relevant because the source pack has Norion around 8-9x trailing/TTM earnings and about 1.15x book; a small multiple change is meaningful for market cap. The buyback has direct per-share mechanics. The 5.9m shares repurchased through 2026-05-22 equal about 3.1% of total shares. If the remaining roughly SEK 185m were deployed around SEK 59.10, Norion could retire another approximately 3.1m shares, bringing the 2026 program near 9.0m shares, or about 4.8% of the current share count. That helps EPS and ROE per share if bought below intrinsic value and if capital is genuinely surplus. The caveat: buybacks consume capital, and bank capital only deserves to be distributed if credit quality, regulatory outcomes and funding remain under control. Bank liquidity itself is not the trading-risk problem today. Q1 2026 reported SEK 15.5bn total liquidity, LCR 490% an

Norion Bank - area 25: ma_strategic_value. Key findings: **Hard facts.** Norion is building Wealth Management through bolt-on M&A, not a transformative bank merger. Consensus was acquired via a SEK 22.50 per share cash offer, valuing it at about SEK 171m. At announcement, Consensus had SEK 8.8bn AUM, SEK 64.5m LTM revenue, 34 employees and seven offices. Norion later controlled about 96.77% of shares and 96.14% of votes and moved to squeeze-out and delisting. Strand adds about SEK 6bn AUM and SEK 29m 2025 revenue, with 12 employees. Norion says Consensus plus Strand gives about SEK 15bn AUM and a platform aimed at entrepreneurs and business owners, with cross-selling primarily into Corporate and Real Estate. Fee revenue should require less regulatory capital than balance-sheet lending, useful for a bank whose valuation debate centers on ROE, Stage 3 and capital returns. **Interpretation.** The M&A strategy is strategically coherent but not yet large enough to carry the equity case. A rough disclosed revenue base of SEK 93.5m is small against FY 2025 total income of SEK 3,847m. Even if Wealth Management earns a better multiple than specialist lending, the starting scale is tiny beside the loan book, capital base and credit-risk debate. The most important strategic-value item is control, not Strand. Balder distributed 90.5m Norion shares, equal to 47.7% of Norion, to Balder shareholders. AMN 2026:15 states that after the distribution Erik Selin controls about 37.4% of Norion privately and through wholly owned companies, with no mandatory bid, and can acquire more shares without mandatory bid. That creates genuine optionality. Optionality is not the same as an offer. A take-private still needs financing, regulatory comfort, minority process, and a solution for funding instruments. The base prospectus gives MTN holders a put righ

Norion Bank - area 25: ma_strategic_value. Valuation/per-share implications: M&A affects valuation in three ways. First, it can modestly improve earnings quality. If Consensus and Strand grow from the SEK 15bn AUM base, Norion gets more fee income and less dependence on risk-weighted lending. Near term, disclosed revenue is only about 2.4% of FY 2025 group income, so the right adjustment is a small strategic option, not a heroic multiple rewrite. Second, it can influence P/B through perceived business quality. A bank with mid-teens ROE, falling Stage 3, active buybacks and rising fee income deserves a better multiple than a pure specialist lender with messy credit. If Stage 3 remains high or AML ends badly, investors will not pay much for a wealth-management side quest. Third, Selin optionality can affect the equity risk/reward. AMN removes one mandatory-bid friction point and confirms that Selin can increase ownership. That raises the probability of gradual control tightening and creates a possible bid-premium tail. It does not create a floor. For the parent model, treat Consensus/Strand as a small positive mix option and Selin control as a separate strategic optionality variable. Do not bury both inside a generic "higher multiple" assumption.

Norion Bank - area 26: esg_reputation. Key findings: **Fakta:** ESG is not cosmetic for Norion. The bank's materiality assessment correctly points to the loan book and customer conduct as the relevant ESG battlefield. Own operational emissions are tiny next to financed emissions; the actual risk sits in Corporate/Real Estate credit selection, Consumer affordability, Payments/Walley customer flows, data handling, and compliance. **Fakta:** Norion has built visible ESG infrastructure: board-level policy responsibility, a Chief Sustainability Officer, an Ethics Committee, external whistleblowing, ESG credit assessments, a red-list/exclusion logic, green bond framework, green register, and annual sustainability reporting inspired by ESRS. ESG analysis covered 88% of the credit portfolio at year-end 2025. Useful, but not proof of portfolio-wide risk reduction. **Fakta:** The biggest reputation overhang is AML. The FI investigation started in May 2023, covers general risk assessment, customer risk assessment and KYC measures, and moved into a sanctions process after FI's preliminary January 2025 assessment that Norion had breached AML rules. Norion has answered follow-up questions through January 2026. Q1 2026 still says timing and outcome are unknown. The prospectus warns of sanctions, process changes, added resources, management distraction, reputation damage, and, in severe cases, license implications. **Fakta:** Customer/conduct metrics were not flashing red in the 2025 annual report: 0 personal-integrity breaches, 3 material complaints versus 6 in 2024, 0 product/service information non-compliance cases, and 0 marketing-communication non-compliance cases. The caveat is that these are company-defined reported metrics. They do not prove absence of customer friction across Walley/Collector, especially given invoice, delpaymen

Norion Bank - area 26: esg_reputation. Valuation/per-share implications: This area mainly affects the acceptable P/B and P/E multiple, not near-term EPS modeling unless FI imposes a large sanction or remediation costs. Base case should carry an AML/reputation discount until final FI outcome is known. If FI closes the matter cleanly, the discount can narrow and support buybacks/excess-capital confidence. If FI imposes a serious sanction, the impact can come through four channels: one-off cost, higher recurring compliance expense, lower buyback capacity or willingness, and a higher cost of deposits/wholesale funding. The ESG positives are real but probably secondary for valuation today. Green bonds, ESG credit processes and low reported customer-integrity incidents support funding access and lower tail-risk perception. They do not offset the unresolved AML process by themselves. In a P/B framework, this area argues for a governance/regulatory risk adjustment rather than an ESG premium.

Norion Bank - area 27: industry_module_bank_specialty_finance. Key findings: **Hard facts.** Norion is a regulated Nordic niche-finance bank with four operating segments. The balance sheet is driven by Real Estate, Corporate, Consumer and Payments rather than low-risk prime mortgages. Q1 2026 loans to the public were SEK 51.458bn: Real Estate 42%, Consumer 27%, Corporate 23%, Payments 7%. Q1 net profit was SEK 301m, period ROE 12.1%, and adjusted ROE excluding excess capital 14.0%. Credit quality is the central industry issue. Stage 3 gross loans were SEK 10.633bn at Q1 2026, 18.8% of gross loans. Net Stage 3 was 11.4%, total provisions were SEK 5.426bn, and provision ratio was 9.6%. Stage 3 coverage was 45.2%, with private customers at 60.3% and corporate customers at 22.3%. Lower corporate coverage is not automatically reckless because those loans are usually collateralized, but it makes collateral value and recovery timing critical. Funding looks strong today but is not free. Deposits and borrowings from the public were SEK 53.714bn at Q1, about 78% of the balance sheet. Total liquidity was SEK 15.520bn, LCR was 490%, and NSFR was 128%. The catch is that the prospectus flags FI's stance on digital deposit platforms: platform deposits can require harsher LCR/NSFR treatment because they may be more flighty. For a deposit-funded niche bank, deposit pricing, platform mix and confidence are earnings-quality inputs. Capital is currently a support, not a constraint. Q1 CET1 was 15.6% against a 9.2% CET1 requirement; total capital ratio was 18.4% against a 13.2% total requirement. Management targets buffers 200-400 bps above requirements and reports SEK 1.277bn excess capital versus the midpoint target. The May 2026 SEK 300m AT1 issue improves capital-stack efficiency but adds coupon cost and does not solve credit quality. **Interpretation.** Norion

Norion Bank - area 27: industry_module_bank_specialty_finance. Valuation/per-share implications: The industry module mainly affects valuation through sustainable ROE, cost of equity, credit-loss assumptions and capital-return capacity. At the source-pack market cap of about SEK 11.216bn, Norion trades around 1.15x Q1 book and 8.5x simple TTM earnings. Those multiples look cheap if the bank sustains mid-teens ROE and returns excess capital. They look fair if investors assign a high risk premium to Stage 3, AML and funding sensitivity. Per-share upside mechanisms: lower Stage 3 frees NII and provisions, CET1 surplus supports buybacks, and Payments/Wealth Management can improve earnings mix. Per-share downside mechanisms: credit losses consume earnings and capital, FI outcomes or funding costs reduce distributable surplus, and real estate stress can make book value less clean than reported equity implies. For P/B, the key test is whether Norion is a temporarily messy mid-teens ROE bank or structurally a higher-risk niche lender. For P/E, the key test is normalized credit losses and whether Q1 2025's SEK 140m Stage 3 interest receipt should be excluded. For CET1 and buybacks, the test is whether RWEA, provisioning and AML remediation stay inside the capital plan.

Norion Bank - area 34: size_module_midcap. Key findings: **Hard facts.** Norion is a Mid Cap listed bank with one share class and 189,782,534 shares after cancellation of 15,598,470 treasury shares in February 2026. Q1 2026 loan portfolio was SEK 51.5bn, net profit SEK 301m, EPS SEK 1.54, ROE 12.1%, adjusted ROE 14.0%, CET1 15.6%, total capital ratio 18.4%, LCR 490%, and NSFR 128%. FY 2025 net profit was SEK 1.44bn and ROE was 15.5%. The segment mix is not "generic bank". Corporate is 23% of loans, Real Estate 42%, Consumer 27%, and Payments 7%. Q1 operating profit was Corporate SEK 138m, Real Estate SEK 159m, Consumer SEK 114m, Payments SEK 41m, and Other SEK -63m. Payments has high NIM and transaction growth, but Real Estate and Consumer credit still dominate. Ownership changed materially after the source-pack baseline. Balder distributed 90,501,180 shares, equal to 47.7% of Norion, to Balder shareholders. FI flagging then shows Balder at effectively zero, while Erik Selin moved to 71.24m shares or 37.54%. The Balder block is gone legally, but control and secondary-flow risk remain. **Interpretation.** Norion has moved beyond micro/small-cap financing risk. The midcap question is whether excess capital, buybacks, and profitability can overcome the credibility discount from Stage 3 exposure, Real Estate concentration, and AML/FI process risk. Capital allocation is unusually active: buybacks, AT1/T2 optimization, Consensus/Strand wealth-management M&A, and capital release ambitions are live at once. That works only if above-15% ROE and asset-quality repair hold.

Norion Bank - area 34: size_module_midcap. Valuation/per-share implications: At SEK 59.10 and 189.8m shares, market cap is about SEK 11.2bn. Against Q1 2026 equity of SEK 9.77bn, P/B is about 1.15x. Against FY 2025 net profit of SEK 1.44bn, P/E is about 7.8x using market-cap/net-profit arithmetic. On Q1 annualized EPS of SEK 6.16, the same price implies about 9.6x, but Q1 is not clean normalized earnings. The midcap valuation hinge is simple: a bank sustaining 15%+ ROE with controlled credit losses should not be stuck at a low single-digit earnings multiple forever. If normalized ROE is closer to 12%, or Stage 3 consumes capital, the apparent cheapness is partly deserved. Buybacks are the clearest per-share lever. A full SEK 500m buyback at SEK 59.10 would retire roughly 8.5m shares, or about 4.5% of current shares, before considering shares already bought. The SEK 300m AT1 is not common-share dilution, but coupon cost and capital-stack complexity still matter.